RAD54L2P1

Across TCGA pan-cancer cohorts, RAD54L2P1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RAD54L2P1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RAD54L2P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RAD54L2P1 expression acts as an unfavorable survival marker, although some lineages such as TGCT and HNSC show a favorable association.

LUAD, ACC, and SKCM are the cancer types where RAD54L2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.232	0.689	<.001	126	view →
ACC	OS	Tertile	All	0.285	0.809	.001	81	view →
SKCM	DFS	Tertile	III,IV	0.036	0.597	<.001	69	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
THYM	DFS	Tertile	All	0.403	0.824	.007	33	view →
KIRP	OS	Tertile	All	0.414	0.714	<.001	30	view →
STAD	OS	Tertile	II,III,IV	0.509	0.746	.014	27	view →
TGCT	DFS	Tertile	All	0.922	0.733	.008	18	view →
SARC	OS	Tertile	All	0.493	0.782	.008	18	view →
HNSC	OS	Tertile	II,III,IV	0.921	0.743	.034	15	view →
KIRC	DFS	Quartile	IV	0.342	0.652	.008	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RAD54L2P1–LUAD (OS)

Open the LUAD breakdown →